Drug intelligence / Profile preview

Yinhu Jiedu decoction

Development stage: Unknown
Lead developer: The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Yinhu Jiedu decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by The Third Affiliated Hospital of Beijing University of Chinese Medicine for the treatment of acne vulgaris, specifically targeting the gastrointestinal damp-heat syndrome pattern. Administered orally, the decoction is designed to reduce inflammatory skin lesions by modulating the skin microbiota and inhibiting Th17-related inflammatory pathways. It is currently being evaluated in Phase 2 clinical trials in China to assess its clinical efficacy, safety, and impact on TCM syndrome scores compared to tanshinone capsules.

Other names: Yinhu Jiedu Decoction

Beyond the preview

Go deeper on Yinhu Jiedu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinhu Jiedu decoction.

Explore the full profile